|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.27 BRL | +1.39% |
|
+0.83% | -9.91% |
| 07/03 | Transcript : Dexco S.A., Q4 2023 Earnings Call, Mar 07, 2024 | |
| 07/03 | Dexco S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Dexco S.A. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was BRL 2,131 million compared to BRL 1,768.13 million a year ago. Net income was BRL 223.59 million compared to BRL 172.63 million a year ago.
Basic earnings per share from continuing operations was BRL 0.2737 compared to BRL 0.207 a year ago. Diluted earnings per share from continuing operations was BRL 0.2725 compared to BRL 0.2057 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.91% | 1.16B | |
| +3.66% | 5.36B | |
| +3.54% | 3.33B | |
| +4.81% | 1.39B | |
| +20.32% | 1.24B | |
| -7.86% | 749M | |
| -20.54% | 707M | |
| +10.55% | 548M | |
| -14.00% | 529M | |
| -26.25% | 465M |
DEXCO S.A. 
